TWD
RGNX icon

True Wealth Design’s Regenxbio RGNX Stock Holding History

True Wealth Design’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.34K Buy
529
+340
+180% +$2.82K ﹤0.01% 1235
2026
Q1 		$1.58K Sell
189
-330
-64% -$3.47K ﹤0.01% 1632
2025
Q4 		$7.47K Buy
519
+83
+19% +$1.03K ﹤0.01% 946
2025
Q3 		$4.21K Buy
436
+362
+489% +$3.2K ﹤0.01% 1150
2025
Q2 		$608 Sell
74
-31
-30% -$259 ﹤0.01% 1662
2025
Q1 		$751 Buy
105
+89
+556% +$662 ﹤0.01% 1381
2024
Q4 		$124 Buy
+16
New +$150 ﹤0.01% 1267

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

True Wealth Design's RGNX Position: Q2 2026 in Review

True Wealth Design increased its Regenxbio (RGNX) stake by 180% in Q2 2026, buying an estimated $2.82K and bringing the position to 529 shares worth $6.34K. The position accounts for ﹤0.01% of the portfolio, ranked #1235.

True Wealth Design first reported a position in RGNX in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.47K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • True Wealth Design held 529 shares of Regenxbio worth $6.34K as of Q2 2026.
  • True Wealth Design bought 340 Regenxbio shares in Q2 2026, an estimated $2.82K.
  • Regenxbio made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1235 holding.
  • True Wealth Design first reported a position in Regenxbio in Q4 2024 and has held it in 7 quarters since.
  • True Wealth Design's Regenxbio position peaked at $7.47K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.